| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/11/2009 | US7572896 Monoclonal antibodies that bind to antigen oncostatin M receptor beta subunit (OSM-R.beta); cancers |
| 08/11/2009 | US7572892 Cytokine zalpha11 ligand fusion proteins |
| 08/11/2009 | US7572890 Having activities to inhibit Hemagglutination by Influenza Viruses; lacks dihydrofolate reductase, possesses resistance to both neomycin and methotrexate |
| 08/11/2009 | US7572889 Bt toxin receptors from lepidopteran insects |
| 08/11/2009 | US7572888 Fusion protein comprising arrestin and green fluorescent protein for use in identifying ligands for g-protein coupled receptors |
| 08/11/2009 | US7572887 Gene expressed in prostate cancer, methods and use thereof |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572882 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 08/11/2009 | US7572768 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 08/11/2009 | US7572763 Controlling cell differentiation; muscular disorders |
| 08/11/2009 | US7572762 Materials and methods relating to the induction of apoptosis in target cells |
| 08/11/2009 | US7572635 Method for agrobacterium transformation for dihaploid corn plants |
| 08/11/2009 | US7572634 Compositions and methods for locating preferred integration sites within the genome of a plant |
| 08/11/2009 | US7572633 Use of the adenoviral E2 late promoter |
| 08/11/2009 | US7572629 A gene construct incorporating any two luciferase genes which emit lights with different colors using an identical substrate such that the gene can be stably expressed in mammalian cells; optimize a reporter gene capable of determining or quantifying multiple transcription activities simultaneosly |
| 08/11/2009 | US7572628 Eukaryotic layered vector initiation systems |
| 08/11/2009 | US7572623 Supplying a suspension of cells in a treatment volume, which includes two electrodes in fluid contact with the suspension, applying a time varying bipolar electric potential across the electrode creating an electric field to porate the cell(s) |
| 08/11/2009 | US7572619 Using immortalized trangenic cell to express antihemophilic factor and blood coagulation factor IX for treatment of blood disorders |
| 08/11/2009 | US7572618 Atherosclerosis; coronary heart disease; encodes a polypeptide that is capable of lowering the level of LDL uptake in mammalian cells |
| 08/11/2009 | US7572617 Thermostable ribonuclease H obtained from Archeoglobus profundus |
| 08/11/2009 | US7572616 Combating disorders affecting mitochondrial oxidative phosphorylation system by allotopic expression of the cyanide-insensitive alternative oxidase (AOX) in human cells; polynucleotide obtained from Mollusca, Nematoda and Chordata; metabolic, cardiovascular, genetic, and nervous system disorders |
| 08/11/2009 | US7572609 Increased production of Coenzyme Q-10 by microorganisms of Rhodobacter sphaeroides which have been transformed with gene(s) of the mevalonate (mev) operon from a different microorganism |
| 08/11/2009 | US7572602 Nucleic acid encoding endolysin fusion protein |
| 08/11/2009 | US7572594 Screening assays for agonists or antagonists or receptor activator of NF-κB |
| 08/11/2009 | US7572589 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
| 08/11/2009 | US7572587 CryET29 (delta-endotoxin with activity against fleas and beetles); insecticidal activity against not only insects of the order Coleoptera, but also against fleas, and in particular larvae of the cat flea, Ctenocephalides felis |
| 08/11/2009 | US7572580 Promoter variants of the alpha-7 nicotinic acetylcholine receptor |
| 08/11/2009 | US7572579 HIV; screened easily and rapidly for a candidate compound of an antivirus drug which effects on a resistant virus of a polymerase, integrase and protease inhibitors; drug screening |
| 08/11/2009 | US7572578 Contacting a sample solution containing nucleic acid to a solid phase for adsorption, washing the solid phase with nucleic acid adsorbed, eluting the nucleic acid from solid solution; easy and efficient |
| 08/11/2009 | US7572577 Comprising reverse transcription (RT) of mRNA; polymerase chain reaction; highly sensitive ; can be partially or fully automated |
| 08/11/2009 | US7572576 Analyzing two or more polymorphisms selected from among 4 gene polymorphisms having been revealed as relating to hypertension determining the genotype of a nucleic acid sample based on the polymorphism data obtained in first step, predicting the genetic risk ; high accuracy |
| 08/11/2009 | US7572466 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 08/11/2009 | US7572455 bovine viral diarrhea virus; point mutations; glycoproteins; RNAse inhibition |
| 08/11/2009 | US7572453 Envelope glycoproteins; capsids; immunogens |
| 08/11/2009 | US7572438 Mutant having uracil phosphoribosyl transferase activity |
| 08/11/2009 | US7572437 Long acting human interferon analogs |
| 08/11/2009 | CA2438574C Method of detecting nucleotide polymorphism |
| 08/11/2009 | CA2348732C Human h37 proteins and cdnas encoding the same |
| 08/11/2009 | CA2342300C Mutant luciferase having increased thermostability |
| 08/11/2009 | CA2328133C Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 08/11/2009 | CA2289283C Metastasis models using green fluorescent protein (gfp) as a marker |
| 08/11/2009 | CA2287521C Human recombinant beta-interferon with improved solubility |
| 08/11/2009 | CA2271248C Use of a notch ligand in immunotherapy |
| 08/11/2009 | CA2241572C Apo-2 ligand |
| 08/11/2009 | CA2236699C Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 08/11/2009 | CA2224404C Cell volume-regulated human kinase h-sgk |
| 08/11/2009 | CA2192940C Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 08/10/2009 | WO2009122962A1 Method of producing transformed plant by using agrobacterium strain |
| 08/06/2009 | WO2009097540A1 Methods, compositions, and systems for production of recombinant spider silk polypeptides |
| 08/06/2009 | WO2009097418A2 Sr-bi as a predictor of elevated high density lipoprotein and cardiovascular disease |
| 08/06/2009 | WO2009097351A2 TAK1-D MEDIATED INDUCTION OF CELL DEATH IN HUMAN CANCER CELLS BY SPECIFIC SEQUENCE SHORT DOUBLE STRANDED RNAs |
| 08/06/2009 | WO2009097346A2 Isolated alcohol dehydrogenase enzymes and uses thereof |
| 08/06/2009 | WO2009097331A1 Very long chain polyunsaturated fatty acids, methods of production, and uses |
| 08/06/2009 | WO2009097129A1 Recombinant virus production using mammalian cells in suspension |
| 08/06/2009 | WO2009097077A2 Wound healing compositions and treatments |
| 08/06/2009 | WO2009096900A1 Regeneration and mass propagation of jatropha curcas through somatic embryogenesis |
| 08/06/2009 | WO2009096690A2 Improved promoter, and a production method for l-lysine using the same |
| 08/06/2009 | WO2009096612A1 Regulation of neutrotransmittter release through anion channels |
| 08/06/2009 | WO2009096541A1 Method of producing cysteine derivative |
| 08/06/2009 | WO2009096443A1 Novel method of highly efficiently isolating fungal and/or plant mutants by clarifying quenching process of singlet oxygen and enhancing molecules participating in the process |
| 08/06/2009 | WO2009096162A1 Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody |
| 08/06/2009 | WO2009096112A1 Tag peptide and use thereof |
| 08/06/2009 | WO2009096101A1 Method for introducing foreign gene into early embryo of primate animal, and method for production of transgenic primate animal comprising the introduction method |
| 08/06/2009 | WO2009096088A1 Arthritogenic peptide |
| 08/06/2009 | WO2009095922A1 Method for protecting plants from stress and senescence |
| 08/06/2009 | WO2009095887A1 Cationic sirnas, synthesis and use for interfering rna |
| 08/06/2009 | WO2009095881A2 Plants having altered growth and/or development and a method for making the same |
| 08/06/2009 | WO2009095857A1 Multimeric proteins able to induce an antibody response against the beta-amyloid and use thereof |
| 08/06/2009 | WO2009095791A1 Reverse genetics of negative-strand rna viruses in yeast |
| 08/06/2009 | WO2009095719A2 Use of crac inhibitors and cysteinyl leukotriene inhibitors for treating allergy and asthma |
| 08/06/2009 | WO2009095715A1 Cytokinin riboside phosphorylase from potato and its use |
| 08/06/2009 | WO2009095641A2 Enhanced plant growth |
| 08/06/2009 | WO2009095518A1 Heterologous protection against pasteurella multocida provided by p. multocida fur cells and the outer-membrane protein extracts thereof |
| 08/06/2009 | WO2009095517A2 Methods and compositions capable of causing post-transcriptional silencing of gene expression in a synergic manner |
| 08/06/2009 | WO2009095455A1 Plants having increased yield-related traits and a method for making the same |
| 08/06/2009 | WO2009095452A1 Crystal structure of the atpase domain of proteins of the hsp70 family |
| 08/06/2009 | WO2009095403A1 Expression system and uses thereof for the production of human long pentraxin 3 |
| 08/06/2009 | WO2009095372A1 Methods and compositions using klotho-fgf fusion polypeptides |
| 08/06/2009 | WO2009095366A1 Method for producing sclareol |
| 08/06/2009 | WO2009095226A2 NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS |
| 08/06/2009 | WO2009095183A1 System and method for large-scale infiltration of plants |
| 08/06/2009 | WO2009095059A1 Rubber biosynthesis promoters from taraxacum koksaghyz and their use |
| 08/06/2009 | WO2009095000A2 Method for sequencing an rna molecule by means of mass spectrometry |
| 08/06/2009 | WO2009094772A1 Methods and apparatus for particle introduction and recovery |
| 08/06/2009 | WO2009094755A1 Monoclonal antibodies for ebola and marburg viruses |
| 08/06/2009 | WO2009094742A1 Toxin of the spider phoneutria nigriventer for treatment of erectile dysfunction |
| 08/06/2009 | WO2009094726A1 Plasmodial polynucleotides, proteins and uses thereof |
| 08/06/2009 | WO2009094713A1 Diagnosis and treatment of sensory defect |
| 08/06/2009 | WO2009094704A1 Seed specific expression in plants |
| 08/06/2009 | WO2009079220A3 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 08/06/2009 | WO2009067218A3 Glucoamylase variants with altered properties |
| 08/06/2009 | WO2009066919A3 Gpt gene as a marker for selecting plant transformant |
| 08/06/2009 | WO2009061841A3 Modified polynucleotides as antidotes to antisense compounds |
| 08/06/2009 | WO2009061429A3 Global transcription machinery engineering targeting the rnap alpha subunit (rpoa) |
| 08/06/2009 | WO2009061130A3 Cell permeable runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same |
| 08/06/2009 | WO2009052242A3 Axmi-066 and axmi-076: delta-endotoxin proteins and methods for their use |
| 08/06/2009 | WO2009047002A3 Products and their use for the diagnosis, prevention, and/or care of human and/or animal pathologies characterised by the anomalous deposition of b-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 08/06/2009 | WO2009017803A8 Antisense microrna and uses therefor |
| 08/06/2009 | WO2009004085A3 Dsrna for treating viral infection |
| 08/06/2009 | WO2008150463A8 Use of genetically modified organisms to generate biomass degrading enzymes |